Delaware RHTP — Diabetes Wellness / Continuous Glucose Monitoring (HSS26063)

HSS26063 funds continuous glucose monitoring (CGM) devices and support services for rural patients managing diabetes in Kent and Sussex counties. The $950,000 Year 1 investment positions CGM as a rural health equity tool: CGM technology has significantly improved diabetes management outcomes, but cost and access barriers limit its uptake among rural, low-income, and uninsured patients who are overrepresented in Delaware's rural population.

This solicitation sits within the "Affordable Care and Chronic Disease Management" theme — it is a clinical services investment, not an equipment procurement. Applicants are expected to be health service organizations that will deploy CGM within a patient care framework. CGM programs require clinical oversight — a licensed prescriber must order CGM, and a care team must support patients in interpreting and acting on glucose data. Applications from clinical organizations (FQHCs, clinics) will have structural advantages over pure community organizations without clinical components.

Expected eligible applicant types include FQHCs and FQHC look-alikes serving rural Delaware patients with diabetes; rural healthcare providers and clinics; local health departments; nonprofits operating rural diabetes management programs; and diabetes education organizations with rural reach.

Download the full RFP (HSS26063-HLIRDDWP) at mmp.delaware.gov/Bids to confirm verbatim eligibility language and program requirements.